Figure 4. CIR of the HRD-HSCT group and the chemotherapy-alone group of patients with intermediate- and high-risk AML.
Figure 4

CIR of the HRD-HSCT group and the chemotherapy-alone group of patients with intermediate- and high-risk AML.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal